Table 4.
Neuroprotective | ||||
---|---|---|---|---|
Compound | Dose/Route/ Duration |
Model | Major Mechanisms | Reference |
α-Bisabolol | 5, 25, and 250 μmol/L for 7 days | Rotenone (500 μmol/L) induced neurotoxicity in Drosophila | ↓ mortality and motor deficits, ↓ thiol level ↑ SOD, CAT and Keap1 |
[46] |
α-Bisabolol | 50 mg/kg i.p, 30 min before rotenone for 4 weeks | Rotenone (2.5 mg/kg) induced Parkinson’s disease | ⇥ neuronal loss, ↓ MDA, ↑ GSH, SOD and CAT, ↓ glial activation, ↓ IL-1β, IL-6, TNF-α, iNOS and COX-2, ↑ Bcl-2, ↓ Bax, caspases-3, 9 and cytochrome-C, restored ATP and MC-I activity | [47] |
α-Bisabolol | 5, 10 μg/mL for 2 h in N2a cells and 25, 50 and 100 μg/mL in elegans | Aβ25–35 peptide (50 μM for 24 h) induced toxicity in N2a cells and Caenorhabditis elegans CL4176 and CL2006 | ⇥ cholinesterase and β-secretase, ↓ ROS and RNS ↓ Bax and caspase-3 ↓ ace-1, hsp-4 and Aβ genes |
[49] |
α-Bisabolol | 5 mg/mL for 2 h | Aβ25–35 peptide (50 μM for 24 h) induced toxicity in PC12 cells | ↓ Aβ aggregation ↑ cell survival |
[50] |
α-Bisabolol | 5 and 10 μg/mL for 2 h | Aβ25–35 peptide (50 μM for 24 h) induced toxicity in Neuro-2a cells | ↓ ROS and RNS, ↓ β-secretase and AchE activities, ↓ Bax, caspase3, and ↑ Bcl-2 | [51] |
α-Bisabolol β-D-fucopyranoside | 10–50 μg/mL | Aβ25–35 (100 μM for 24 h, 48 h, 96 h, 9 d) induced toxicity in Neuro 2a cells | Inhibited AChE, ↓ H2O2 and OH•, ↓ Aβ aggregation ↑ cell survival |
[52] |
α-Bisabolol | 50, 100 and 200 mg/kg/day, p.o | Permanent occlusion of the middle cerebral artery induced cerebral ischemia in mice | ↓ infarct size, ↑ motor performance, ↑ crossings and rearings | [54] |
Symbols indications: ↑; increase, ↓; decrease, ⇥; activity inhibition.